ATLASense is addressing healthcare’s most significant and growing challenge: transitioning care from hospitals to homes safely and cost-effectively while preventing life-threatening events. Introducing REPHAEL: the world’s first wearable platform delivering ICU-level monitoring and predictive insights anywhere—hospital, home, or on the go. REPHAEL isn’t just a monitor; it PREDICTS, detects, and alerts healthcare teams to critical risks like respiratory failure, sepsis, heart failure, and falls—days before they escalate. By enabling SAFE, informed clinical decisions remotely ensure hospital-level care at home.
REPHAEL allows ICU-Grade Precision: Continuous, comprehensive monitoring powered by proprietary sensors and AI-driven insights. Its economical advantage: A reusable device that serves multiple patients with various morbidities, offering the lowest cost of use compared to any alternative. Enabling SAFE Decisions: Provides doctors with actionable, predictive data.
